Find clinical trials for Eczema in Atlanta, GA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Eczema trials near Atlanta, GA, USA:
The purpose of this study is to measure how well taking lebrikizumab alone works for participants with fewer places on the body with eczema ...
Phase 4
Atlanta, Georgia, United States and 43 other locations
This trial is designed to evaluate multiple compounds in participants with moderate to severe atopic dermatitis (AD).
Phase 2
Atlanta, Georgia, United States and 10 other locations
This is a phase IIa, randomized, double-blind, placebo-controlled, multi-center proof-of-concept (POC) study in subjects with moderate to severe Atop...
Phase 2
Sandy Springs, Georgia, United States and 26 other locations
The primary objective of the study is to assess the long-term safety of dupilumab in pediatric participants with AD.The secondary objectives of the s...
Phase 3
Sandy Springs, Georgia, United States and 83 other locations
The purpose of this study is to assess the efficacy and safety of barzolvolimab in adults with Atopic Dermatitis
Phase 2
Atlanta, Georgia, United States and 24 other locations
This study is being conducted to establish the efficacy of ruxolitinib cream in participants with moderate AD who had an inadequate response to, or a...
Phase 3
Marietta, Georgia, United States and 96 other locations
The study is designed to evaluate the long-term safety and efficacy of GSK1070806 in participants with moderate-to severe atopic dermatitis, who have...
Phase 2
Fayetteville, Georgia, United States and 58 other locations
This study is parallel group, placebo-controlled dose-ranging study to evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of GSK10...
Phase 2
Fayetteville, Georgia, United States and 92 other locations
The purpose of this study is to assess the efficacy and safety of RO7790121 in participants with moderate to severe atopic dermatitis (AD).
Phase 2
Atlanta, Georgia, United States and 12 other locations
B7451015 is a Phase 3 study to evaluate Abrocitinib with or without Topical Medications in patients aged 12 years and older who have moderate to seve...
Phase 3
Johns Creek, Georgia, United States and 536 other locations
Clinical trials
Research sites
Resources
Legal